# 2025-04044: DEA Okays LSD and THC Factory? Sigma Aldrich Goes Full Mad Scientist

2025-04044, Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-03-13, effective 2025-05-12 (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04044
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04044
- Title: Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 11998
- Published: 2025-03-13
- Effective: 2025-05-12
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

DEA Okays LSD and THC Factory? Sigma Aldrich Goes Full Mad Scientist

## Summary

Sigma Aldrich Research Biochemicals Inc. wants to become a big-time maker of certain controlled substances, including some well-known drugs like LSD and THC. People and companies involved with these substances can share their thoughts or ask for a hearing by May 12, 2025. This move could impact how these drugs are produced and regulated, but no direct costs are mentioned yet.

## Abstract

Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-04044 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/13/2025-04044/bulk-manufacturer-of-controlled-substances-application-sigma-aldrich-research-biochemicals-inc)
- [2025-04044 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-13/pdf/2025-04044.pdf)

## Related
- [Previous: 2025-04043, Importer of Controlled Substances Application: Meridian Medical Technologies, L…](https://policyrisk.com/federal-register/2025-04043)
- [Next: 2025-04045, Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals…](https://policyrisk.com/federal-register/2025-04045)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04044 (as of 2026-09-30).
